Annual Operating Profit
-$6.48 M
+$94.85 M+93.60%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual operating income is -$6.48 million, with the most recent change of +$94.85 million (+93.60%) on December 31, 2023.
- During the last 3 years, CTMX annual operating profit has risen by +$74.06 million (+91.95%).
- CTMX annual operating profit is now at all-time high.
Performance
CTMX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$4.11 M
+$12.56 M+148.64%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly operating income is $4.11 million, with the most recent change of +$12.56 million (+148.64%) on September 30, 2024.
- Over the past year, CTMX quarterly operating profit has increased by +$988.00 thousand (+31.64%).
- CTMX quarterly operating profit is now -64.73% below its all-time high of $11.66 million, reached on March 31, 2024.
Performance
CTMX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$6.71 M
+$988.00 K+17.27%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM operating income is $6.71 million, with the most recent change of +$988.00 thousand (+17.27%) on September 30, 2024.
- Over the past year, CTMX TTM operating profit has increased by +$22.10 million (+143.61%).
- CTMX TTM operating profit is now -38.02% below its all-time high of $10.83 million, reached on March 31, 2024.
Performance
CTMX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CTMX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +93.6% | +31.6% | +143.6% |
| 3 y3 years | +92.0% | +31.6% | +143.6% |
| 5 y5 years | +91.7% | +31.6% | +143.6% |
CTMX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.4% | -64.7% | +107.0% | -38.0% | +104.5% |
| 5 y | 5-year | at high | +95.4% | -64.7% | +106.0% | -38.0% | +104.5% |
| alltime | all time | at high | +95.4% | -64.7% | +106.0% | -38.0% | +104.5% |
CytomX Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.11 M(-148.6%) | $6.71 M(+17.3%) |
| Jun 2024 | - | -$8.45 M(-172.5%) | $5.72 M(-47.1%) |
| Mar 2024 | - | $11.66 M(-2023.6%) | $10.83 M(-267.0%) |
| Dec 2023 | -$6.48 M(-93.6%) | -$606.00 K(-119.4%) | -$6.48 M(-57.9%) |
| Sep 2023 | - | $3.12 M(-193.3%) | -$15.39 M(-68.1%) |
| Jun 2023 | - | -$3.35 M(-40.8%) | -$48.22 M(-35.6%) |
| Mar 2023 | - | -$5.65 M(-40.5%) | -$74.92 M(-26.1%) |
| Dec 2022 | -$101.33 M(-12.7%) | -$9.51 M(-68.0%) | -$101.33 M(-32.6%) |
| Sep 2022 | - | -$29.71 M(-1.1%) | -$150.40 M(+4.9%) |
| Jun 2022 | - | -$30.05 M(-6.3%) | -$143.33 M(+8.2%) |
| Mar 2022 | - | -$32.06 M(-45.3%) | -$132.48 M(+14.2%) |
| Dec 2021 | -$116.04 M(+44.1%) | -$58.57 M(+158.7%) | -$116.04 M(+11.4%) |
| Sep 2021 | - | -$22.64 M(+17.9%) | -$104.19 M(+8.0%) |
| Jun 2021 | - | -$19.20 M(+22.9%) | -$96.44 M(+3.3%) |
| Mar 2021 | - | -$15.63 M(-66.5%) | -$93.37 M(+15.9%) |
| Dec 2020 | -$80.54 M(-43.1%) | -$46.71 M(+213.6%) | -$80.54 M(-20.9%) |
| Sep 2020 | - | -$14.89 M(-7.7%) | -$101.79 M(-9.6%) |
| Jun 2020 | - | -$16.14 M(+477.8%) | -$112.61 M(-11.8%) |
| Mar 2020 | - | -$2.79 M(-95.9%) | -$127.71 M(-9.7%) |
| Dec 2019 | -$141.48 M | -$67.97 M(+164.3%) | -$141.48 M(+42.4%) |
| Sep 2019 | - | -$25.72 M(-17.7%) | -$99.33 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$31.23 M(+88.5%) | -$96.78 M(+22.8%) |
| Mar 2019 | - | -$16.57 M(-35.8%) | -$78.81 M(+1.2%) |
| Dec 2018 | -$77.87 M(+68.3%) | -$25.81 M(+11.4%) | -$77.87 M(+46.1%) |
| Sep 2018 | - | -$23.18 M(+74.8%) | -$53.31 M(+29.5%) |
| Jun 2018 | - | -$13.26 M(-15.2%) | -$41.16 M(-22.7%) |
| Mar 2018 | - | -$15.63 M(+1153.4%) | -$53.27 M(+15.2%) |
| Dec 2017 | -$46.26 M(-22.4%) | -$1.25 M(-88.7%) | -$46.26 M(-21.9%) |
| Sep 2017 | - | -$11.03 M(-56.5%) | -$59.24 M(-6.2%) |
| Jun 2017 | - | -$25.37 M(+194.6%) | -$63.13 M(+21.4%) |
| Mar 2017 | - | -$8.61 M(-39.5%) | -$52.02 M(-12.7%) |
| Dec 2016 | -$59.59 M(+79.5%) | -$14.23 M(-4.6%) | -$59.59 M(+4.8%) |
| Sep 2016 | - | -$14.92 M(+4.6%) | -$56.88 M(+6.9%) |
| Jun 2016 | - | -$14.26 M(-11.9%) | -$53.23 M(+19.6%) |
| Mar 2016 | - | -$16.18 M(+40.4%) | -$44.52 M(+34.1%) |
| Dec 2015 | -$33.20 M(+11.6%) | -$11.52 M(+2.3%) | -$33.20 M(+26.1%) |
| Sep 2015 | - | -$11.27 M(+103.3%) | -$26.34 M(+42.1%) |
| Jun 2015 | - | -$5.54 M(+13.8%) | -$18.53 M(+42.7%) |
| Mar 2015 | - | -$4.87 M(+4.5%) | -$12.99 M(+59.9%) |
| Dec 2014 | -$29.77 M(+99.0%) | -$4.66 M(+34.5%) | -$8.12 M(+134.5%) |
| Sep 2014 | - | -$3.46 M | -$3.46 M |
| Dec 2013 | -$14.96 M | - | - |
FAQ
- What is CytomX Therapeutics annual operating income?
- What is the all time high annual operating profit for CytomX Therapeutics?
- What is CytomX Therapeutics annual operating profit year-on-year change?
- What is CytomX Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly operating profit year-on-year change?
- What is CytomX Therapeutics TTM operating income?
- What is the all time high TTM operating profit for CytomX Therapeutics?
- What is CytomX Therapeutics TTM operating profit year-on-year change?
What is CytomX Therapeutics annual operating income?
The current annual operating profit of CTMX is -$6.48 M
What is the all time high annual operating profit for CytomX Therapeutics?
CytomX Therapeutics all-time high annual operating income is -$6.48 M
What is CytomX Therapeutics annual operating profit year-on-year change?
Over the past year, CTMX annual operating income has changed by +$94.85 M (+93.60%)
What is CytomX Therapeutics quarterly operating income?
The current quarterly operating profit of CTMX is $4.11 M
What is the all time high quarterly operating profit for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly operating income is $11.66 M
What is CytomX Therapeutics quarterly operating profit year-on-year change?
Over the past year, CTMX quarterly operating income has changed by +$988.00 K (+31.64%)
What is CytomX Therapeutics TTM operating income?
The current TTM operating profit of CTMX is $6.71 M
What is the all time high TTM operating profit for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM operating income is $10.83 M
What is CytomX Therapeutics TTM operating profit year-on-year change?
Over the past year, CTMX TTM operating income has changed by +$22.10 M (+143.61%)